Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|
| Total reported revenue | 10.5B | 10.6B | 10.1B | 9.0B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 3.3B | 3.0B | 3.0B | -2.1B |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 532.9M | 897.4M | 357.6M | 2.7B |
| Tax provision | 111.8M | 234.4M | 100.0M | 605.4M |
| Net income | 421.1M | 663.0M | 257.6M | 2.1B |
| Basic EPS | — | 0.6 | 0.2 | — |
| Diluted EPS | — | 0.6 | 0.2 | — |
| Basic average shares | — | 1.1B | 1.1B | — |
| Diluted average shares | — | 1.1B | 1.2B | — |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |